Riluzone may help survival in motor neurone diseaseBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6930.678 (Published 12 March 1994) Cite this as: BMJ 1994;308:678
- J Roberts
A French research team has reported a small gain in the understanding of amyotrophic lateral sclerosis. But although there was widespread news coverage about it in Europe and the United States, scientists remain sceptical.
Amyotrophic lateral sclerosis affects upper motor neurones, and little more is known about it today than when it was first described by Charcot in 1865. It is a rare disease, striking about 1 in 100 000 adults a year, and is progressive, destroying neurones in the cortex, brain stem, and spinal cord. It is inevitably fatal, killing patients in middle age usually within four years of onset. It has claimed the lives of several well known people, such as the actor David Niven and the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial